Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.06 USD | +3.31% | +8.81% | +9.79% |
May. 08 | Maxim Initiates NeuroBo Pharmaceuticals With Buy Rating, $10 Price Target | MT |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.79% | 19.28M | |
+2.74% | 108B | |
+10.08% | 105B | |
+1.57% | 23.46B | |
-11.89% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.95% | 17.19B | |
+5.98% | 13.99B | |
+36.10% | 12.53B |
- Stock Market
- Equities
- NRBO Stock
- News NeuroBo Pharmaceuticals, Inc.
- NeuroBo Gets FDA Clearance For DA-1726 Trial in Obesity; Shares Soar